Comparative Study of Cytotoxicity and Accumulation of Boron and Lithium-Containing Drugs in Skin Melanoma Cells In Vitro

Bull Exp Biol Med. 2024 Oct;177(6):736-740. doi: 10.1007/s10517-024-06260-3. Epub 2024 Oct 23.

Abstract

We studied cytotoxicity and accumulation of boron and lithium by cultured human fibroblasts and human and mouse skin melanoma cell cultures. The cytotoxicity of boron and lithium drugs was assessed by MTT tests in the boron and lithium concentration range of 10-640 μg/ml. Cell viability was significantly reduced after incubation with boron and lithium at concentrations >160 μg/ml. To assess accumulation of boron and lithium, the concentration of elements was measured using inductively coupled plasma atomic emission spectrometry. Melanoma cells more intensively accumulated lithium in comparison with boron. The results indicate the possibility of safe application of lithium salts in concentrations minimally required for successful neutron capture therapy.

Keywords: borocaptate; boronophenylalanine; lithium salts; neutron capture therapy; skin melanoma.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Boron
  • Boron Neutron Capture Therapy / methods
  • Cell Line, Tumor
  • Cell Survival* / drug effects
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Humans
  • Lithium
  • Melanoma* / drug therapy
  • Melanoma* / metabolism
  • Melanoma* / pathology
  • Mice
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / metabolism
  • Skin Neoplasms* / pathology

Substances

  • Boron
  • Lithium